课题基金 / 基金详情

2006 FASEB SRC on Lymphocytes and Antibodies

2006 FASEB SRC on Lymphocytes and Antibodies
2006 年 FASEB SRC 关于淋巴细胞和抗体
批准号:
7161177
负责人:
Marc Kevin Jenkins
金额:
$1.1万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2007-05-31

项目摘要

项目成果

Marc Kevin Jenkins的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal requests partial support for the 2006 Federation of American Societies of Experimental Biology (FASEB) Summer Conference on ?Lymphocytes and Antibodies?, which has been held every other summer for the past 20 years. The purpose of the meeting is to bring together basic immunologists from academia and the pharmaceutical industry at the professorial, post-doctoral and pre-doctoral levels to present and discuss cutting-edge research in basic immunology. The meeting will focus on new discoveries concerning the organs, cells, and molecules that play key roles in innate and adaptive immunity. The conference should also be attractive to savvy clinical researchers who know that the next generation of therapies will come from the kind of basic science discoveries presented at this conference. The time-tested format will consist of oral presentations by international leaders in the field and poster presentations by other attendees. A major strength of the meeting is that the participants stay in a secluded resort and share meals for the length of the conference. This total immersion atmosphere is very conducive to in depth discussions and collaboration-building for attendees at all levels. This conference will serve as the definitive small meeting with a broad focus on basic immunology in 2006.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection and Activation of CD4+ T cells with Low Affinity TCRs
  • 批准号:
    10348758
  • 项目类别:
  • 资助金额:
    $38.32万
  • 财政年份:
    2019
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Detection and Activation of CD4+ T cells with Low Affinity TCRs
  • 批准号:
    10570243
  • 项目类别:
  • 资助金额:
    $38.32万
  • 财政年份:
    2019
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Protective CD4+ T Cells
  • 批准号:
    10349513
  • 项目类别:
  • 资助金额:
    $46.74万
  • 财政年份:
    2013
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Protective CD4+ T cells
  • 批准号:
    8430702
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2013
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
国内基金
海外基金
流感病毒感染T淋巴细胞并致感染细胞异常死亡机制研究
  • 批准号:
    81970010
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2019
  • 负责人:
    曹彬
  • 依托单位:
microRNA15a/16-1对B细胞及其介导的炎症性肠病恶性转化的调控研究
  • 批准号:
    81601362
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.5万元
  • 批准年份:
    2016
  • 负责人:
    刘荣花
  • 依托单位:
用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
  • 批准号:
    81041002
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    岑溪南
  • 依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
  • 批准号:
    30760248
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2007
  • 负责人:
    周源
  • 依托单位: